Europe Medical Cannabis Market - Industry Trends and Forecast to 2028

Segmentation

Short Description Europe Medical Cannabis Market, By Product (Oil, Dried Medical Cannabis, Medical Cannabis Capsules, Vape Pen, Whole Flower, Creams & Moisturizer, Ground Flower, Patch, Mask & Serum, Cleanser, Others), Source (Natural, Synthetic), Species (Sativa, Hybrid, Cannabis Indica), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/Delta-8-Tetrahydrocannabinol, Cannabigerol (CBG), Cannabinol, Others), Application (Pain Management, Anxiety, Muscle Spasms, Nausea, Appetite Loss, Cancer, Arthritis, Alzheimer's Disease, Epilepsy, Depression and Sleep Disorders, Multiple Sclerosis, Autism, Mental Health Conditions, Elevate Mood, Others), Route of Administration (Oral Solutions and Capsules, Smoking, Topicals, Vaporizers, Others), End User (Homecare Settings, Hospital and Rehab Centers, Pharmaceutical Industry, Research and Development Centers, Others), Distribution Channel (B2C, B2B), Country (Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Rest of Europe) Industry Trends and Forecast to 2028 Market Definition: Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. For several years, it has been used medicinally and has wide range of applications in treatment of various diseases including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS and Alzheimers among others. Market Segmentation: The medical cannabis market is categorized into eight notable segments which are based on the product, source, species, derivatives, application, route of administration, end user and distribution channel. On the basis of product, the medical cannabis market is segmented into oil, medical cannabis capsules, patch, whole flower, ground flower, vape pen, dried medical cannabis, creams & moisturizer, mask & serum, cleanser and others On the basis of source, the medical cannabis market is segmented into synthetic and natural On the basis of species, the medical cannabis market is segmented into cannabis indica, sativa and hybrid On the basis of derivatives, the medical cannabis market is segmented into cannabidiol (CBD), tetrahydrocannabinol (THC)/delta-8-tetrahydrocannabinol, cannabinol, cannabigerol (CBG) and others On the basis of application, the medical cannabis market is segmented into Alzheimers disease, appetite loss, cancer, epilepsy, autism, mental health conditions, multiple sclerosis, pain management, nausea, muscle spasms, arthritis, elevate mood, depression and sleep disorders, anxiety and others On the basis of route of administration, the medical cannabis market is segmented into oral solutions and capsules, smoking, vaporizers, topicals and others On the basis of end user, the medical cannabis market is segmented into pharmaceutical industry, research and development centers, homecare settings, hospital and rehab centers and others On the basis of distribution channel, the medical cannabis market is segmented into B2B and B2C Market Players The key market players for Europe medical cannabis market are listed below: Tilray Elixinol Europe Limited Medical Marijuana, Inc. Peace Naturals Project Inc. BOL Pharma PharmaHemp Kiehls (a subsidiary of L'ORAL) ENDOCA CANOPY GROWTH CORPORATION Aurora Cannabis GW Pharmaceuticals plc Althea Company Pty Ltd (a subsidiary of Althea Group) Cresco Labs IDT Australia MediPharm Labs Inc. BARNEY'S FARM Aphria Inc.

Methodology